3.92亿资金抢筹航天发展，机构狂买新金路丨龙虎榜

Core Viewpoint - On November 28, the Shanghai Composite Index rose by 0.34%, the Shenzhen Component Index increased by 0.85%, and the ChiNext Index went up by 0.7%. The most significant net inflow of funds was into Aerospace Development (000547.SZ), amounting to 392 million yuan, while the largest net outflow was from Zhongsheng Pharmaceutical (002317.SZ), totaling 277 million yuan [1][3]. Group 1: Stock Performance - Aerospace Development saw a closing price increase of 10.02% with a turnover rate of 25.76% and a net buying amount of 392.34 million yuan, accounting for 7.59% of the total trading volume [3][4]. - Zhongsheng Pharmaceutical experienced a closing price drop of 10% with a turnover rate of 18.78% and a net selling amount of 276.59 million yuan, representing 7.84% of the total trading volume [4][10]. Group 2: Institutional Activity - A total of 25 stocks appeared on the trading leaderboard, with institutions participating in 18 stocks, resulting in a net buying amount of 505 million yuan [4][5]. - The stock with the highest institutional net buying was New Jin Road (000510.SZ), which closed up by 5.65% and had a turnover rate of 39.07% [5][6]. Group 3: Northbound Capital - Northbound capital participated in 18 stocks, with a total net outflow of 93.56 million yuan, where the most significant net buying was in Aerospace Development, amounting to 92.68 million yuan [10][13]. - The stock with the highest net selling by northbound capital was Shida Group (600734.SH), with a net outflow of 102 million yuan, closing down by 8.3% [10][14]. Group 4: Divergence in Institutional and Northbound Capital - There was a divergence in the trading of certain stocks, such as Haiwang Biological, where institutions sold 22.34 million yuan while northbound capital bought 442.09 million yuan [13][14]. - In the case of Wanrun New Energy, institutions net bought 32.63 million yuan, while northbound capital net sold 51.75 million yuan [13][14].